About
Brian Zaboski, PhD, is an Assistant Professor of Psychiatry at the Yale School of Medicine. He holds dual expertise as a licensed Connecticut psychologist and Nationally Certified School Psychologist. His primary academic affiliation is with the Obsessive Compulsive Disorder Research Clinic within the Department of Psychiatry. Dr. Zaboski completed his PhD in School Psychology at the University of Florida, gaining clinical experience across school-based to acute inpatient settings. He specializes in cognitive-behavioral therapy (CBT) and exposure-based interventions for psychological disorders, with particular focus on OCD neurobiology and treatment innovation.
His research integrates advanced quantitative methods and translational neuroscience to improve exposure therapy efficacy. Key areas include neurobiological network analysis, machine learning applications for OCD severity prediction, and neurofeedback treatment trials. He leads clinical trials investigating psilocybin therapy, pharmacotherapy combinations, and brain network changes in OCD patients. Dr. Zaboski's work has been funded by prestigious grants including the 2022 Brain & Behavior Research Foundation Young Investigator Award.
Collaborations include prominent researchers like Christopher Pittenger, Terence Ching, and Michelle Hampson. His publications span peer-reviewed journals in psychiatry, neuroscience, and school psychology, with a focus on OCD mechanisms, treatment innovation, and school-based mental health interventions. Clinical trials he participates in explore novel treatments like troriluzole and psilocybin while investigating biomarkers for treatment response prediction.
